PMA P170008S037

Device
EluNIRâ„¢ Ridaforolimus Eluting Coronary Stent System
Applicant
Medinol, Ltd.
Product code
NIQ
Decision date
2023-10-20
Generic name
Coronary drug-eluting stent
Approval order statement
Approval for the addition of radiopaque (RO) markers to the stent edges and RO coating to the internal distal tip material.

Current openFDA PMA Record#

Device
EluNIRâ„¢ Ridaforolimus Eluting Coronary Stent System
Applicant
Medinol, Ltd.
PMA number
P170008
Supplement
S037
Product code
NIQ
Generic name
Coronary drug-eluting stent
Decision date
2023-10-20
Decision code
APPR
Date received
2021-09-15
Supplement type
Normal 180 Day Track
Supplement reason
Change Design/Components/Specifications/Material
Approval order statement
Approval for the addition of radiopaque (RO) markers to the stent edges and RO coating to the internal distal tip material.